Population Health (179)

Dr. Sameer Vohra, director of the Illinois Department of Public Health, says its mission is modernizing data that will improve communities' well-being by driving smarter, faster public health decisions.

Saad Alhuzami of the Kingdom of Saudi Arabia's Ministry of Health discusses how the Kingdom is leveraging AI-powered screenings for chronic diseases and creating digital twins that reflect patients' medical histories and risk factors.

From retinal scans to aging clocks, AI is likely to shift healthcare from reactive treatment to proactive prevention, especially in aging populations, says Andrew Steele, author of "Ageless: The New Science of Getting Older Without Getting Old".

Olga Kagan, Food Allergy Nursing Association (FANA) president & CEO and 2025 Changemaker Award recipient, says she launched FANA to educate nurses about the emerging health concern so they can deliver adequate care and better advocate for patients.

Dr. Anwar Jebran, medical director of population health informatics at Oak Street Health, says he's "only getting positive feedback" about ambient tools – but urges caution for the next phase of AI apps, prioritizing accuracy and safety.

Aimee Corso, senior vice president of growth at Mirvie, discusses the company's pregnancy-focused women's health company and its new offering, a direct-to-consumer test to predict preeclampsia before it occurs using RNA analysis.

Dr. Sy Saeed of the North Carolina Statewide Telepsychiatry Program talks about how the state's MOTHeRS Project has helped virtually connect high-risk pregnant women in rural areas to OB-GYN, mental health and diabetes care.

Piedmont Healthcare's population health pharmacy program manager, Melissa Robinson, discusses a predictive analytics tool that helps the health system identify and engage patients at risk for medication non-adherence.

Studying data from a clinic serving high-risk Medicaid patients helped Davies Awardee Dr. Robert Jarve and his team from Corewell Health understand what's driving most of the clinic's ED utilization.

Without alignment of primary and specialty care, hospital and post-acute care, the goals of value-based care are virtually unattainable, says HSBlox operations chief Lynn Carroll.

Russ Lebovitz, CEO of Amprion, discusses the company’s partnership with Mayo Clinic Laboratories to expand access to its test that detects misfolded proteins associated with Parkinson’s, Lewy body dementia, and multiple system atrophy.

Dan Shields, CEO of digital medicine at Ochsner Health, discusses the health system's 10-year project that leverages proven digital tools to help patients with conditions such as hypertension and diabetes better manage their care.